Literature DB >> 1989386

Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel.

R J Sugrue1, A J Hay.   

Abstract

The evidence presented shows that the M2 protein of influenza A viruses exists in infected cells as a homotetramer composed of two disulfide-linked dimers held together by noncovalent interactions. The amphiphilic nature of the transmembrane alpha-helical domain is consistent with the protein forming a transmembrane channel with which amantadine, the specific anti-influenza A drug, interacts. Together these features provide a structural basis for the hypothesis that M2 has a proton translocation function capable of regulating the pH of vesicles of the trans-Golgi network, a role important in promoting the correct maturation of the hemagglutinin glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1989386      PMCID: PMC7131614          DOI: 10.1016/0042-6822(91)90075-m

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  24 in total

1.  An open-channel blocker interacts with adjacent turns of alpha-helices in the nicotinic acetylcholine receptor.

Authors:  P Charnet; C Labarca; R J Leonard; N J Vogelaar; L Czyzyk; A Gouin; N Davidson; H A Lester
Journal:  Neuron       Date:  1990-01       Impact factor: 17.173

2.  Quaternary structure of influenza virus hemagglutinin after acid treatment.

Authors:  R W Doms; A Helenius
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

Review 3.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  [3H]Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic, antiviral, and antiarrhythmic drugs.

Authors:  A T Eldefrawi; E R Miller; D L Murphy; M E Eldefrawi
Journal:  Mol Pharmacol       Date:  1982-07       Impact factor: 4.436

5.  Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection.

Authors:  R B Belshe; M H Smith; C B Hall; R Betts; A J Hay
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

6.  Determination of the orientation of an integral membrane protein and sites of glycosylation by oligonucleotide-directed mutagenesis: influenza B virus NB glycoprotein lacks a cleavable signal sequence and has an extracellular NH2-terminal region.

Authors:  M A Williams; R A Lamb
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

7.  Molecular basis of resistance of influenza A viruses to amantadine.

Authors:  A J Hay; M C Zambon; A J Wolstenholme; J J Skehel; M H Smith
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

8.  Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.

Authors:  S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

9.  Specific structural alteration of the influenza haemagglutinin by amantadine.

Authors:  R J Sugrue; G Bahadur; M C Zambon; M Hall-Smith; A R Douglas; A J Hay
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

10.  The molecular basis of the specific anti-influenza action of amantadine.

Authors:  A J Hay; A J Wolstenholme; J J Skehel; M H Smith
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  169 in total

1.  Definitive assignment of proton selectivity and attoampere unitary current to the M2 ion channel protein of influenza A virus.

Authors:  T I Lin; C Schroeder
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Transmembrane domain of M2 protein from influenza A virus studied by solid-state (15)N polarization inversion spin exchange at magic angle NMR.

Authors:  Z Song; F A Kovacs; J Wang; J K Denny; S C Shekar; J R Quine; T A Cross
Journal:  Biophys J       Date:  2000-08       Impact factor: 4.033

4.  Conditional ablation of T-cell development by a novel viral ion channel transgene.

Authors:  Claire A Smith; Christine M Graham; Kathleen Mathers; Anita Skinner; Alan J Hay; Cornelia Schroeder; D Brian Thomas
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

5.  Molecular dynamics simulation of proton transport near the surface of a phospholipid membrane.

Authors:  Alexander M Smondyrev; Gregory A Voth
Journal:  Biophys J       Date:  2002-03       Impact factor: 4.033

6.  Mapping the energy surface of transmembrane helix-helix interactions.

Authors:  J Torres; A Kukol; I T Arkin
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

7.  Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus.

Authors:  K Tobler; M L Kelly; L H Pinto; R A Lamb
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  The NB protein of influenza B virus is not necessary for virus replication in vitro.

Authors:  Masato Hatta; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  Restriction of viral replication by mutation of the influenza virus matrix protein.

Authors:  Teresa Liu; Zhiping Ye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 10.  Influenza M2 proton channels.

Authors:  Rafal M Pielak; James J Chou
Journal:  Biochim Biophys Acta       Date:  2010-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.